Hepatitis A screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Overview
There is no recommended screening guideline for Hepatitis A infection in the general population. However, screening is often performed in young adult migrants, refugees, and adopted children. The detection of hepatitis A virus (HAV) antibodies in the blood is used to screen for hepatitis A. Anti-HAV IgG remains elevated after acute disease.[1][2]
Screening
Screening
A positive anti-HAV IgG result demonstrates that the person is immune to hepatitis A due to: [1]
- Previous HAV infection, or
- Hepatitis A vaccination
A negative test demonstrates that the person:[1]
- Has never been infected with HAV
- Has never been vaccinated against HAV
- Is vulnerable to the HAV infection
References
References
- ↑ 1.0 1.1 1.2 “Hepatitis A Screening”.
- ↑ Fishbain JT, Eckart RE, Harner KC, Hospenthal DR (2002). “Empiric immunization versus serologic screening: developing a cost-effective strategy for the use of hepatitis A immunization in travelers”. J Travel Med. 9 (2): 71–5. PMID 12044273.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH